GlassScriptPhysician profile
Kyle Michael Kidwell
NPI 1013570829
$788.75
in general payments reported to CMS, 2019-2025
14 companies · $583 in 2025
The $583 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $121 · 2023: $84.99 · 2025: $583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $583 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $583.16 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $184.98 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $166.88 | 2025 | Enhertu |
| Genzyme Corporation | $116.16 | 2025 | |
| Daiichi Sankyo INC. | $49.11 | 2025 | Enhertu, Datroway |
| Incyte Corporation | $43.06 | 2025 | Zynyz, Monjuvi |
| Glaxosmithkline, LLC. | $41.49 | 2025 | Ojjaara, Blenrep |
| Sobi, INC | $33.12 | 2025 | |
| Recordati_rare_diseases_inc. | $30.43 | 2025 | Enjaymo |
| Bayer Healthcare Pharmaceuticals INC. | $27.27 | 2025 | |
| Emd Serono, INC. | $24.37 | 2025 | |
| Kite Pharma, INC. | $20.61 | 2022 | |
| Tempus Ai, INC | $18.67 | 2025 | Xt Cdx |
| Pfizer INC. | $16.89 | 2025 | |
| Novocure INC. | $15.71 | 2025 | Optune Lua (Novottf-200t) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Kidwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.